Entecavir and Tacrolimus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Entecavir (entecavir) and Tacrolimus (tacrolimus). Common drug interactions include white blood cell count increased among females and blood creatinine increased among males.
The phase IV clinical study analyzes what interactions people have when they take Entecavir and Tacrolimus. It is created by eHealthMe based on reports of 403 people who take the same drugs from the FDA, and is updated regularly.
What is Entecavir?
Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.
What is Tacrolimus?
Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
403 people who take Entecavir and Tacrolimus together, and have interactions are studied.
What are the common drug interactions of Entecavir and Tacrolimus, by gender? *
What are the common drug interactions of Entecavir and Tacrolimus, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Entecavir and Tacrolimus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Entecavir (7,354 reports)
- Tacrolimus (116,160 reports)
Browse all drug interactions of Entecavir and Tacrolimus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Entecavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tacrolimus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Entecavir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tacrolimus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on entecavir and tacrolimus (the active ingredients of Entecavir and Tacrolimus, respectively), and Entecavir and Tacrolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lamotrigine and Ethosuximide - 4 seconds ago
- Could Fentanyl cause Chronic Obstructive Pulmonary Disease? - 6 seconds ago
- Could Dimenhydrinate cause Indigestion? - 10 seconds ago
- Synthroid and Uti for Women aged 60+ - 13 seconds ago
- Synthroid and Cystitis for Women aged 60+ - 13 seconds ago
- Synthroid and Bladder Infection for Women aged 60+ - 13 seconds ago
- Synthroid and Urinary Tract Infection for Women aged 60+ - 13 seconds ago
- Electrolyte Imbalance and Blood Creatine Phosphokinase Increased - 16 seconds ago
- Cascara and Headache for Women aged 40-49 - 37 seconds ago
- Cascara and Frequent Headaches for Women aged 40-49 - 37 seconds ago